ProgynyPGNY
About: Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
Employees: 680
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
179% more call options, than puts
Call options by funds: $8.57M | Put options by funds: $3.07M
2.06% more ownership
Funds ownership: 95.64% [Q3] → 97.7% (+2.06%) [Q4]
2% more capital invested
Capital invested by funds: $1.4B [Q3] → $1.44B (+$30.8M) [Q4]
7% less funds holding
Funds holding: 283 [Q3] → 262 (-21) [Q4]
20% less repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 96
25% less first-time investments, than exits
New positions opened: 54 | Existing positions closed: 72
67% less funds holding in top 10
Funds holding in top 10: 3 [Q3] → 1 (-2) [Q4]
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
BTIG David Larsen 27% 1-year accuracy 4 / 15 met price target | 31%upside $28 | Buy Upgraded | 31 Mar 2025 |
Canaccord Genuity Richard Close 32% 1-year accuracy 8 / 25 met price target | 8%upside $23 | Hold Maintained | 28 Feb 2025 |
B of A Securities Michael Cherny 69% 1-year accuracy 20 / 29 met price target | 17%upside $25 | Buy Maintained | 11 Feb 2025 |
JP Morgan Anne Samuel 47% 1-year accuracy 16 / 34 met price target | 8%upside $23 | Neutral Maintained | 28 Jan 2025 |
Financial journalist opinion
Based on 5 articles about PGNY published over the past 30 days









